Other OTC - Delayed Quote USD

CS Diagnostics Corp. (FZRO)

0.1900 0.0000 (0.00%)
As of May 14 at 9:36 AM EDT. Market Open.
Loading Chart for FZRO
DELL
  • Previous Close 0.1900
  • Open 0.1900
  • Bid --
  • Ask --
  • Day's Range 0.1900 - 0.1900
  • 52 Week Range 0.0215 - 6.2500
  • Volume 3,115
  • Avg. Volume 697
  • Market Cap (intraday) 51,409
  • Beta (5Y Monthly) -16.67
  • PE Ratio (TTM) --
  • EPS (TTM) -1,038,497.4375
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.

cs-diagnostics.de

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FZRO

Performance Overview: FZRO

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FZRO
62.00%
S&P 500
10.91%

1-Year Return

FZRO
89.44%
S&P 500
28.27%

3-Year Return

FZRO
96.20%
S&P 500
26.74%

5-Year Return

FZRO
92.40%
S&P 500
86.64%

Compare To: FZRO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FZRO

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    51.41k

  • Enterprise Value

    51.41k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -316.07%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -341.61k

  • Diluted EPS (ttm)

    -1,038,497.4375

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    37.38k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    157.69k

Research Analysis: FZRO

Company Insights: FZRO

Research Reports: FZRO

People Also Watch